Troy Edward Wilson, President and CEO at Kura Oncology, Inc. (KURA), sold 113,289 shares at $22.00 ($1.9M) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Open-market sale of $1.9M KURA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 26,041 | $0 | 0.0% |
| 2 | $22.00 | 12,901 | $284K | 14.8% |
| 3 | $22.00 | 50,000 | $1.1M | 57.2% |
| 4 | $22.00 | 521 | $11K | 0.6% |
| 5 | $22.09 | 11,913 | $263K | 13.7% |
| 6 | $22.09 | 11,913 |
| $263K |
| 13.7% |
| Total | $16.96 avg | 113,289 | $1.9M | 100% |
| Filing → |
| KURA | BUY | 2026-08-17 | $1.1M | — | Filing → |
| PBYI | SELL | 2026-06-15 | $78K | — | Filing → |
| KURA | SELL | 2025-09-29 | $655K | — | Filing → |